A detailed history of Tower Research Capital LLC (Trc) transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,361 shares of AVNS stock, worth $26,076. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,361
Previous 8,912 84.73%
Holding current value
$26,076
Previous $177,000 81.92%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$19.21 - $24.69 $145,054 - $186,434
-7,551 Reduced 84.73%
1,361 $32,000
Q2 2024

Aug 13, 2024

BUY
$17.85 - $20.42 $88,321 - $101,038
4,948 Added 124.82%
8,912 $177,000
Q1 2024

May 15, 2024

SELL
$17.97 - $22.68 $166,060 - $209,585
-9,241 Reduced 69.98%
3,964 $78,000
Q4 2023

Feb 13, 2024

BUY
$17.64 - $22.99 $182,538 - $237,900
10,348 Added 362.2%
13,205 $296,000
Q3 2023

Nov 14, 2023

BUY
$19.93 - $26.31 $936 - $1,236
47 Added 1.67%
2,857 $57,000
Q2 2023

Aug 14, 2023

BUY
$22.53 - $30.98 $36,250 - $49,846
1,609 Added 133.97%
2,810 $71,000
Q1 2023

May 09, 2023

SELL
$26.92 - $31.75 $26 - $31
-1 Reduced 0.08%
1,201 $36,000
Q4 2022

Feb 10, 2023

SELL
$19.88 - $27.37 $102,481 - $141,092
-5,155 Reduced 81.09%
1,202 $32,000
Q3 2022

Nov 10, 2022

BUY
$21.56 - $29.59 $89,603 - $122,976
4,156 Added 188.82%
6,357 $139,000
Q2 2022

Aug 15, 2022

BUY
$24.87 - $34.68 $40,761 - $56,840
1,639 Added 291.64%
2,201 $60,000
Q1 2022

May 12, 2022

SELL
$28.87 - $35.77 $25,030 - $31,012
-867 Reduced 60.67%
562 $19,000
Q4 2021

Feb 14, 2022

SELL
$29.25 - $36.02 $150,783 - $185,683
-5,155 Reduced 78.3%
1,429 $50,000
Q3 2021

Nov 15, 2021

SELL
$31.2 - $38.5 $317,803 - $392,161
-10,186 Reduced 60.74%
6,584 $206,000
Q2 2021

Aug 16, 2021

BUY
$36.37 - $45.72 $331,003 - $416,097
9,101 Added 118.67%
16,770 $610,000
Q1 2021

May 17, 2021

BUY
$43.5 - $53.4 $33,321 - $40,904
766 Added 11.1%
7,669 $336,000
Q4 2020

Feb 16, 2021

SELL
$33.15 - $49.5 $2.05 Million - $3.07 Million
-61,922 Reduced 89.97%
6,903 $317,000
Q3 2020

Nov 16, 2020

BUY
$28.67 - $34.32 $1.46 Million - $1.74 Million
50,812 Added 282.09%
68,825 $2.29 Million
Q2 2020

Aug 13, 2020

BUY
$23.48 - $33.86 $421,771 - $608,227
17,963 Added 35926.0%
18,013 $529,000
Q1 2020

May 15, 2020

SELL
$20.64 - $34.41 $1,403 - $2,339
-68 Reduced 57.63%
50 $1,000
Q4 2019

Feb 07, 2020

SELL
$31.89 - $47.34 $24,842 - $36,877
-779 Reduced 86.85%
118 $4,000
Q3 2019

Nov 05, 2019

SELL
$32.06 - $44.0 $76,206 - $104,588
-2,377 Reduced 72.6%
897 $34,000
Q2 2019

Aug 13, 2019

BUY
$37.68 - $46.52 $52,149 - $64,383
1,384 Added 73.23%
3,274 $143,000
Q1 2019

May 14, 2019

BUY
$39.84 - $51.04 $60,317 - $77,274
1,514 Added 402.66%
1,890 $81,000
Q4 2018

Feb 14, 2019

SELL
$41.16 - $66.67 $196,621 - $318,482
-4,777 Reduced 92.7%
376 $17,000
Q3 2018

Nov 13, 2018

BUY
$55.13 - $72.65 $284,084 - $374,365
5,153 New
5,153 $353,000

Others Institutions Holding AVNS

About AVANOS MEDICAL, INC.


  • Ticker AVNS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 46,487,000
  • Market Cap $891M
  • Description
  • Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...
More about AVNS
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.